Valuation: Bio-Rad Laboratories, Inc.

Market Cap 9.7B 8.72B 8.14B 7.38B 13.85B 923B 13.93B 97.67B 38.14B 479B 36.42B 35.63B 1,541B P/E 2026 *
43.6x
P/E 2027 * 42.6x
Enterprise Value 8.95B 8.05B 7.51B 6.81B 12.78B 852B 12.86B 90.13B 35.19B 442B 33.6B 32.88B 1,422B EV / Sales 2026 *
3.48x
EV / Sales 2027 * 3.33x
Free-Float
60.17%
Yield 2026 *
-
Yield 2027 * -
1 day-0.36%
1 week-1.49%
Current month-4.05%
1 month-1.66%
3 months+21.48%
6 months+24.02%
Current year+19.62%
1 week 358.42
Extreme 358.425
371.07
1 month 353.3
Extreme 353.3
390
Current year 236.73
Extreme 236.73
396.23
1 year 236.73
Extreme 236.73
396.23
3 years 211.43
Extreme 211.43
396.23
5 years 211.43
Extreme 211.43
798.97
10 years 154.89
Extreme 154.89
832.7
Manager TitleAgeSince
Chief Executive Officer 76 2002-12-31
President 61 2024-09-08
Director of Finance/CFO 55 2024-04-14
Director TitleAgeSince
Chairman 76 2011-12-31
Director/Board Member 73 2017-04-24
Director/Board Member 79 2017-04-24
Date Insider Type Main position Quantity % Market Cap. Importance
9/6/26 Exercice

General Counsel

1,841 0.0085%
9/6/26 Exercice

Chief Executive Officer

8,764 0.0404%
9/6/26 Exercice

Chief Financial Officer

3,854 0.0178%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%-1.49%+18.81%+5.13% 9.73B
+0.35%+4.29%-22.74%+13.32% 178B
+1.31%+10.20%-2.39%+30.95% 119B
-0.33%+2.26%-23.89%+9.21% 108B
+1.23%+0.99%-45.59%-9.75% 75.27B
+1.84%+5.96%+5.74%+77.89% 62.99B
-1.36%-0.04%+16.43%+64.46% 53.46B
+0.81%+4.85%+0.28%-26.98% 51.04B
+1.67%+4.41%-16.94%+24.13% 40.99B
-1.87%-0.98%+26.07%+9.56% 32.1B
Average +0.31%+2.89%-4.42%+19.79% 73.05B
Weighted average by Cap. +0.49%+4.04%-12.00%+20.03%

Financials

2026 *2027 *
Net sales 2.57B 2.31B 2.16B 1.95B 3.67B 245B 3.69B 25.87B 10.1B 127B 9.65B 9.44B 408B 2.62B 2.36B 2.2B 2B 3.75B 250B 3.77B 26.42B 10.32B 130B 9.85B 9.64B 417B
Net income 225M 202M 189M 171M 321M 21.4B 323M 2.26B 884M 11.11B 844M 826M 35.72B 230M 207M 193M 175M 328M 21.86B 330M 2.31B 903M 11.35B 862M 844M 36.49B
Net Debt -749M -673M -628M -570M -1.07B -71.28B -1.08B -7.54B -2.94B -36.99B -2.81B -2.75B -119B -965M -868M -810M -734M -1.38B -91.87B -1.39B -9.72B -3.8B -47.68B -3.62B -3.55B -153B
Projected Income Statement - Annual - Bio-Rad Laboratories, Inc.
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
26-10-14 $362.43 -0.36% 297,388
26-10-13 $363.73 -0.19% 132,592
26-10-12 $364.42 -0.48% 181,201
26-10-09 $366.16 +1.60% 138,984
26-10-08 $360.40 -2.04% 312,024
Trader
Investor
Global
Quality
ESG MSCI
BBB
MarketScreener Ratings - Bio-Rad Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
362.43USD
Average target price
328.33USD
Spread / Average Target
-9.41%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Bio-Rad Laboratories, Inc.